Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.

GH, Leyten; D, Hessels; FP, Smit; SA, Jannink; Jong H, de; WJ, Melchers; EB, Cornel; Reijke TM, de; H, Vergunst; P, Kil; BC, Knipscheer; de Kaa CA, Hulsbergen-van; PF, Mulders; Oort IM, van; JA, Schalken

doi:10.1158/1078-0432.ccr-14-3334

Public

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.

Shared by NobleBlocks on Mar 18, 2015 • 12:00 AM UTC

Authors:

Leyten GH

Hessels D

Smit FP

Abstract

<h4>Purpose</h4>Serum PSA (sPSA) testing has led to the identification of patients with indolent prostate cancer, and inevitably overtreatment has become a concern. Progensa PCA3 urine testing was shown to improve the diagnosis of prostate cancer, but its diagnostic value for aggressive prostate can...

Discussions